Therapeutic angiogenesis: A comparative study of the angiogenic potential of acidic fibroblast growth factor and heparin
- 1 August 1997
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 26 (2) , 302-312
- https://doi.org/10.1016/s0741-5214(97)70193-9
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Heparin-induced endothelial cell cytoskeletal reorganization: A potential mechanism for vascular relaxationKidney International, 1995
- Role of basic fibroblast growth factor in the regulation of rat basilar artery tone in vivoNeuroscience Letters, 1995
- Longitudinal Changes in Myocardial Basic Fibroblast Growth Factor (FGF-2) Activity Following Coronary Artery Ligation in the DogJournal of Molecular and Cellular Cardiology, 1994
- Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model.Journal of Clinical Investigation, 1994
- bFGF enhances the development of the collateral circulation after acute arterial occlusionBiochemical and Biophysical Research Communications, 1992
- A study of cell proliferation in formalin‐fixed, wax‐embedded bone marrow trephine biopsies using the monoclonal antibody PC10, reactive with proliferating cell nuclear antigen (PCNA)The Journal of Pathology, 1992
- Extracellular matrix heparan sulfate proteoglycans modulate the mitogenic capacity of acidic fibroblast growth factorJournal of Cellular Physiology, 1989
- THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINSAnnual Review of Biochemistry, 1989
- Heparin protects heparin-binding growth factor-I from proteolytic inactivation in vitroBiochemical and Biophysical Research Communications, 1988
- An in vivo model for study of the angiogenic effects of basic fibroblast growth factorBiochemical and Biophysical Research Communications, 1987